DCG(I) has come up with mandatory provisions for pharma companies to undergo stability tests for approval of drugs in India. Though it will raise the standard for quality of drugs in the global market, it will also have considerable impact on pharma company’s bottom line. Industry experts have a mixed bag of opinions
Bhavin Mehta, Director, Kilitch Drugs
The Indian pharmaceutical sector is a huge industry with a significant growth potential. The industry comprises large, medium and small-scale drug companies that are expanding its presence not only in the domestic market, but in the export markets as well. Globally, the industry’s drugs find markets in the US, the European Union, the Middle-East, African continent and South-East Asia. To cater to these growing overseas segments, it is essential that the industry invests significantly in research and development, manufacturing facilities and developing newer markets. Further, to ensure that these are continuously sustained at the beginning stage of a drug’s life cycle as well as at subsequent stages, quality of the drug is an imperative.
With a view to encourage pharma exports, the Government of India has recently amended the provisions of Market Access Initiative (MAI) scheme. In particular, this is important from the perspective of SME pharma players, who are expected to contribute to the industry’s double-digit growth, in no small measure.
While this is a welcome step in the right direction, there is one more recent announcement by the country’s drug regulator, the Central Drugs Standards Control Organisation (CDSCO), which the players are not too happy about. As part of the amendments to Drugs and Cosmetics Rules, 1945, henceforth ‘stability testing’ has been made mandatory for all drugs and formulations before they access the market. The new rule applies to all drugs, active pharmaceutical ingredients (API)s, raw materials used in a drug, new drugs and even to older drugs which are already in the market for a long time.
Denne historien er fra March 01-15, 2019-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra March 01-15, 2019-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
MAKING SUSTAINABILITY SUSTAINABLE
Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, MSME pharma companies need to carefully balance their sustainability goals with financial viability
New energy recovery system for tablet coaters
Upto 50 per cent less steam energy consumption
The future of pharma logistics: Trends, challenges, and opportunities
Nikhil Agarwal, President, CJ Darcl Logistics explains that the future of pharma logistics is a thrilling frontier shaped by technological advancements, regulatory challenges, and the imperative of sustainability. As the industry transforms, logistics providers must embrace innovative solutions and adapt to shifting demands
Achieving Aatmanirbharta In APIs Are We On The Right Track?
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats
Yokogawa launches OpreX Data Model Broker
A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation
Understanding the nuances of generics injectables
At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial
Trending in nutraceuticals: Science meets sustainability
Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe
The growth of e-pharmacies in India
Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these
Xylitol and Maltitol: Low-calorie sugar alternatives
Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste
Single-use TC gaskets and their importance
Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.